Accelmed Partners Ii L.p. - Net Worth and Insider Trading

Accelmed Partners Ii L.p. Net Worth

The estimated net worth of Accelmed Partners Ii L.p. is at least $45 Million dollars as of 2024-11-29. Accelmed Partners Ii L.p. is the 10% Owner of NeuroPace Inc and owns about 4,432,948 shares of NeuroPace Inc (NPCE) stock worth over $45 Million. Details can be seen in Accelmed Partners Ii L.p.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Accelmed Partners Ii L.p. has not made any transactions after 2022-11-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Accelmed Partners Ii L.p.

To

Accelmed Partners Ii L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Accelmed Partners Ii L.p. owns 2 companies in total, including NeuroPace Inc (NPCE) , and Minerva Surgical Inc (UTRS) .

Click here to see the complete history of Accelmed Partners Ii L.p.’s form 4 insider trades.

Insider Ownership Summary of Accelmed Partners Ii L.p.

Ticker Comapny Transaction Date Type of Owner
NPCE NeuroPace Inc 2022-11-22 10 percent owner
UTRS Minerva Surgical Inc 2023-02-09 10 percent owner

Accelmed Partners Ii L.p. Latest Holdings Summary

Accelmed Partners Ii L.p. currently owns a total of 1 stock. Accelmed Partners Ii L.p. owns 4,432,948 shares of NeuroPace Inc (NPCE) as of November 22, 2022, with a value of $45 Million.

Latest Holdings of Accelmed Partners Ii L.p.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NPCE NeuroPace Inc 2022-11-22 4,432,948 10.25 45,437,717

Holding Weightings of Accelmed Partners Ii L.p.


Accelmed Partners Ii L.p. Form 4 Trading Tracker

According to the SEC Form 4 filings, Accelmed Partners Ii L.p. has made a total of 2 transactions in NeuroPace Inc (NPCE) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in NeuroPace Inc is the acquisition of 390,291 shares on November 22, 2022, which cost Accelmed Partners Ii L.p. around $585,436.

Insider Trading History of Accelmed Partners Ii L.p.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Accelmed Partners Ii L.p. Trading Performance

GuruFocus tracks the stock performance after each of Accelmed Partners Ii L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Accelmed Partners Ii L.p. is 216.67%. GuruFocus also compares Accelmed Partners Ii L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Accelmed Partners Ii L.p. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Accelmed Partners Ii L.p.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Accelmed Partners Ii L.p.

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 0.67 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 3.8 LIMIT LIMIT LIMIT LIMIT LIMIT

Accelmed Partners Ii L.p. Ownership Network

Ownership Network List of Accelmed Partners Ii L.p.

No Data

Ownership Network Relation of Accelmed Partners Ii L.p.

Insider Network Chart

Accelmed Partners Ii L.p. Owned Company Details

What does NeuroPace Inc do?

Who are the key executives at NeuroPace Inc?

Accelmed Partners Ii L.p. is the 10 percent owner of NeuroPace Inc. Other key executives at NeuroPace Inc include 10 percent owner Kck Ltd. , 10 percent owner Orbimed Advisors Llc , and Chief Medical officer Martha Morrell .

NeuroPace Inc (NPCE) Insider Trades Summary

Over the past 18 months, Accelmed Partners Ii L.p. made no insider transaction in NeuroPace Inc (NPCE). Other recent insider transactions involving NeuroPace Inc (NPCE) include a net sale of 350,266 shares made by Kck Ltd. , a net sale of 605,946 shares made by Orbimed Advisors Llc , and a net sale of 59,402 shares made by Martha Morrell .

In summary, during the past 3 months, insiders sold 322,928 shares of NeuroPace Inc (NPCE) in total and bought 0 shares, with a net sale of 322,928 shares. During the past 18 months, 1,015,614 shares of NeuroPace Inc (NPCE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,015,614 shares.

NeuroPace Inc (NPCE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

NeuroPace Inc Insider Transactions

No Available Data

Accelmed Partners Ii L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Accelmed Partners Ii L.p.. You might contact Accelmed Partners Ii L.p. via mailing address: 2875 Ne 191st, Suite 500, Aventura Fl 33180.

Discussions on Accelmed Partners Ii L.p.

No discussions yet.